Daegu, South Korea · Founded 2023 · Privately Held (backing)
Developer of hemostatic medical devices designed to control bleeding in emergency and clinical environments. Inopharma is based in Daegu, South Korea and was founded in 2023. Its last reported valuation was $4.2 million in Apr 2026. It has raised $10,000.
Last reported valuation
$4.2M
Oct 2026
Priced at
—
Total raised
$10K
Last round
—
Cap table — not yet on record
Inopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Inopharma with a free account
·Watch Inopharma: the Monday email on marks, rounds and moves
